Japan's House of Representatives passed an amendment to the Health Insurance Law on Thursday [1].
The legislation marks a significant shift in the national healthcare system by removing financial barriers to childbirth and adjusting how the state subsidizes common medications. These changes aim to modernize the medical insurance framework to better support families and reduce the burden on public funds.
Health Minister Ueno said the bill passed on Friday [2]. The amendment, which was approved during the House of Representatives plenary session on May 28 [1], introduces a system to make childbirth costs free for citizens.
Beyond maternal care, the law modifies the High-Cost Medical Expense Benefit system. It also targets the insurance coverage for drugs that contain ingredients similar to those found in over-the-counter medicines [3]. Under the new rules, patients will face an additional burden rate of 25% [3] for these specific types of medications.
The legislative process saw the bill move through the House Welfare Committee on May 24 [4] before reaching the final vote in the plenary session on May 28 [1]. This progression reflects a broader government effort to reform the medical insurance system by balancing expanded social welfare for new parents with cost-cutting measures for routine pharmaceutical treatments.
Minister Ueno said the government intends to refine the delivery of healthcare services following the official approval in Tokyo. The shift toward a 25% additional payment for OTC-like drugs is intended to encourage the use of non-prescription options for minor ailments, thereby preserving insurance resources for more severe medical conditions [3].
“Japan's House of Representatives passed an amendment to the Health Insurance Law”
This legislative shift represents a strategic pivot in Japan's public health policy. By eliminating childbirth costs, the government is directly addressing declining birth rates through financial incentive. Simultaneously, the increased co-payment for OTC-like medications suggests a move toward a more sustainable insurance model that discourages the over-utilization of prescription services for common illnesses.
